Secondary mutations in the kinase domain of the KIT gene are predominant in imatinib-resistant gastrointestinal stromal tumor.

Source:http://linkedlifedata.com/resource/pubmed/id/18294292

Download in:

View as

Triples

General Info

PMID
18294292